- UroToday Home
- Recent Abstracts
- Urologic Oncology
Renal Cancer
Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma - Abstract
August 25, 2011
Brain metastases from renal cell carcinoma. Should we change the current standard? - Abstract
August 25, 2011
Systemic therapy for metastatic non-clear-cell renal cell carcinoma: Recent progress and future directions - Abstract
August 24, 2011
Clinical and molecular prognostic factors in renal cell carcinoma: What we know so far - Abstract
August 24, 2011
Management of treatment-related toxicity with targeted therapies for renal cell carcinoma: Evidence-based practice and best practices - Abstract
August 24, 2011
The role of surgery in advanced renal cell carcinoma: Cytoreductive nephrectomy and metastasectomy - Abstract
August 23, 2011
Vascular endothelial growth factor-targeted therapies in advanced renal cell carcinoma - Abstract
August 23, 2011
mTOR inhibitors in advanced renal cell carcinoma - Abstract
August 23, 2011
Stage-related alterations in renal cell carcinoma - Comprehensive Quantitative Analysis by 2D-DIGE and Protein Network Analysis - Abstract
August 22, 2011
New insights into the biology of renal cell carcinoma - Abstract
August 22, 2011
Imaging in renal cell carcinoma - Abstract
August 22, 2011
Intrinsic resistance to tyrosine kinase inhibitors is associated with poor clinical outcome in metastatic renal cell carcinoma - Abstract
August 19, 2011
Statin use and the risk of renal cell carcinoma in 2 prospective US cohorts - Abstract
August 18, 2011
The epidemiology of renal cell carcinoma - Abstract
August 17, 2011